PCI Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease

Journal of the American College of Cardiology

Volumn 68, Issue 10, 2016, Pages 1066-1081

  Bates, Eric R ^a   Tamis Holland, Jacqueline E ^b   Bittl, John A ^c   O'Gara, Patrick T ^d   Levine, Glenn N ^e  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^c Munroe Regional Med Center   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

myocardial ischemia; myocardial revascularization; outcome assessment

Indexed keywords

ANTITHROMBOCYTIC AGENT;

CLINICAL EFFECTIVENESS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY STENTING; DUAL ANTIPLATELET THERAPY; EVIDENCE BASED MEDICINE; FRACTIONAL FLOW RESERVE; HEART MUSCLE REVASCULARIZATION; HUMAN; MEDICAL DECISION MAKING; META ANALYSIS (TOPIC); MORTALITY; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; REVIEW; RISK REDUCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THERAPY EFFECT; TRANSLUMINAL CORONARY ANGIOPLASTY; PATHOLOGY; PROCEDURES; ST ELEVATION MYOCARDIAL INFARCTION;

CORONARY ARTERY DISEASE; HUMANS; PERCUTANEOUS CORONARY INTERVENTION; ST ELEVATION MYOCARDIAL INFARCTION;

EID: 84994709850     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.05.086     Document Type: Review

References (101)

1. 1 Park, D.W., Clare, R.M., Schulte, P.J., et al. Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction. JAMA 312 (2014), 2019–2027.
2. 2 Muller, D.W., Topol, E.J., Ellis, S.G., et al., Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Am Heart J 121 (1991), 1042–1049.
3. 3 Jaski, B.E., Cohen, J.D., Trausch, J., et al. Outcome of urgent percutaneous transluminal coronary angioplasty in acute myocardial infarction: comparison of single-vessel versus multivessel coronary artery disease. Am Heart J 124 (1992), 1427–1433.
4. 4 Sorajja, P., Gersh, B.J., Cox, D.A., et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J 28 (2007), 1709–1716.
5. 5 Goldstein, J.A., Demetriou, D., Grines, C.L., et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 343 (2000), 915–922.
6. 6 Asakura, M., Ueda, Y., Yamaguchi, O., et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. J Am Coll Cardiol 37 (2001), 1284–1288.
7. 7 Gibson, C.M., Ryan, K.A., Murphy, S.A., et al., TIMI Study Group. Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. J Am Coll Cardiol 34 (1999), 974–982.
8. 8 Grines, C.L., Topol, E.J., Califf, R.M., et al., TAMI Study Group. Prognostic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction. Circulation 80 (1989), 245–253.
9. 9 Parodi, G., Mernisha, G., Valenti, R., et al. Five year outcome after primary coronary intervention for acute ST elevation myocardial infarction: results from a single centre experience. Heart 91 (2005), 1541–1544.
10. 10 Levine, G.N., Bates, E.R., Blankenship, J.C., et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 58 (2011), e44–e122.
11. 11 O'Gara, P., Kushner, F.G., Ascheim, D.D., et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61 (2013), 485–510.
12. 12 Patel, M.R., Dehmer, G.J., Hirshfeld, J.W., et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 59 (2012), 857–881.
13. 13 American College of Cardiology. American College of Cardiology Updates Heart Attack Recommendations. September 19, 2014. Available at: http://www.acc.org/latest-in-cardiology/articles/2014/09/19/16/03/american-college-of-cardiology-updates-heart-attack-recommendations. Accessed June 22, 2016.
14. 14 Windecker, S., Kolh, P., Alfonso, F., et al. 2014 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 35 (2014), 2541–2619.
15. 15 Levine, G.N., O'Gara, P.T., Bates, E.R., et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. J Am Coll Cardiol 67 (2016), 1235–1250.
16. 16 Wald, D.S., Morris, J.K., Wald, N.J., et al., PRAMI Investigators. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med 369 (2013), 1115–1123.
17. 17 Di Mario, C., Mara, S., Flavio, A., et al. Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) study. Int J Cardiovasc Intervent 6 (2004), 128–133.
18. 18 Politi, L., Sgura, F., Rossi, R., et al. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up. Heart 96 (2010), 662–667.
19. 19 Gershlick, A.H., Khan, J.N., Kelly, D.J., et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol 65 (2015), 963–972.
20. 20 Engstrøm, T., Kelbæk, H., Helqvist, S., et al., DANAMI 3-PRIMULTI Investigators. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI 3-PRIMULTI): an open-label, randomised controlled trial. Lancet 386 (2015), 665–671.
21. 21 Ijsselmuiden, A.J., Ezechiels, J., Westendorp, I.C., et al. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison. Am Heart J 148 (2004), 467–474.
22. 22 Chen, L.Y., Lennon, R.J., Grantham, J.A., et al. In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction. Am J Cardiol 95 (2005), 349–354.
23. 23 Lee, H.J., Song, Y.B., Hahn, J.Y., et al. Multivessel vs single-vessel revascularization in patients with non-ST-elevation acute coronary syndrome and multivessel disease in the drug-eluting stent era. Clin Cardiol 3 (2011), 160–165.
24. 24 Kong, J.A., Chou, E.T., Minutello, R.M., et al. Safety of single versus multi-vessel angioplasty for patients with acute myocardial infarction and multi-vessel coronary artery disease: report from the New York State Angioplasty Registry. Coron Artery Dis 17 (2006), 71–75.
25. 25 Jo, H.S., Park, J.S., Sohn, J.W., et al. Culprit-lesion-only versus multivessel revascularization using drug-eluting stents in patients with ST-segment elevation myocardial infarction: a Korean Acute Myocardial Infarction Registry-based analysis. Korean Circ J 41 (2011), 718–725.
26. 26 Abe, D., Sato, A., Hoshi, T., et al. Initial culprit-only versus initial multivessel percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: results from the Ibaraki Cardiovascular Assessment Study registry. Heart Vessels 29 (2014), 171–177.
27. 27 Ryu, K.S., Park, H.W., Park, S.H., et al., other Korea Acute Myocardial Infarction Registry Investigators. Comparison of clinical outcomes between culprit vessel only and multivessel percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel coronary diseases. J Geriatr Cardiol 12 (2015), 208–217.
28. 28 Poyen, V., Labrunie, P., Silvestri, M., et al. [Complete revascularization of multivessel coronary artery disease during acute myocardial infarction. Results following hospitalization and after 30 months. Series of 86 interventions carried out with 167 multivessel disease patients; causes of failure]. Arch Mal Coeur Vaiss 96 (2003), 1149–1156.
29. 29 Kalarus, Z., Lenarczyk, R., Kowalczyk, J., et al. Importance of complete revascularization in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am Heart J 153 (2007), 304–312.
30. 30 Katayama, N., Horiuchi, K., Nakao, K., et al. [Does percutaneous coronary intervention in non-culprit vessels improve the prognosis of acute myocardial infarction complicated by pump failure?]. J Cardiol 46 (2005), 1–8.
31. 31 van der Schaaf, R.J., Claessen, B.E., Vis, M.M., et al. Effect of multivessel coronary disease with or without concurrent chronic total occlusion on one-year mortality in patients treated with primary percutaneous coronary intervention for cardiogenic shock. Am J Cardiol 105 (2010), 955–959.
32. 32 Xu, F., Chen, Y.G., Li, J.F., et al. Multivessel percutaneous coronary intervention in Chinese patients with acute myocardial infarction and simple nonculprit arteries. Am J Med Sci 333 (2007), 376–380.
33. 33 He, Y., Bittl, J.A., Wouhib, A., Normand, S.L.T., Case study in cardiovascular medicine: unprotected left main coronary artery disease. Biondi-Zoccai, G., (eds.) Network Meta-Analysis: Evidence Synthesis With Mixed Treatment Comparison, 2014, Nova Science Publishers, Hauppauge, NY, 285–306.
34. 34 Spiegelhalter, D.J., Abrams, K.R., Myles, J.P., Bayesian Approaches to Clinical Trials and Health Care Evaluations. 2004, Wiley, Chichester, England.
35. 35 Schwarzer G. Package 'meta'. Freiburg, Germany: version 3.8–0, 2012.
36. 36 Kruschke, J.K., Doing Bayesian Data Analysis: A Tutorial With R and BUGS. 2011, Elsevier, Oxford, UK.
37. 37 Thomas, A., O'Hara, B., Ligges, U., et al. Making BUGS Open. R News 6 (2006), 12–17.
38. 38 Corpus, R.A., House, J.A., Marso, S.P., et al. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. Am Heart J 148 (2004), 493–500.
39. 39 Khattab, A.A., Abdel-Wahab, M., Röther, C., Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction. A single-center experience. Clin Res Cardiol 97 (2008), 32–38.
40. 40 Qarawani, D., Nahir, M., Abboud, M., et al. Culprit only versus complete coronary revascularization during primary PCI. Int J Cardiol 123 (2008), 288–292.
41. 41 Varani, E., Balducelli, M., Aquilina, M., et al. Single or multivessel percutaneous coronary intervention in ST-elevation myocardial infarction patients. Catheter Cardiovasc Interv 72 (2008), 927–933.
42. 42 Mohamad, T., Bernal, J.M., Kondur, A., et al. Coronary revascularization strategy for ST elevation myocardial infarction with multivessel disease: experience and results at 1-year follow-up. Am J Ther 18 (2011), 92–100.
43. 43 Kim, M.C., Jeong, M.H., Park, K.H., et al. Three-year outcomes of staged, ad hoc, and culprit-only percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and multivessel disease. Int J Cardiol 176 (2014), 505–507.
44. 44 Cavender, M.A., Milford-Beland, S., Roe, M.T., et al. Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry). Am J Cardiol 104 (2009), 507–513.
45. 45 Toma, M., Buller, C.E., Westerhout, C.M., et al., APEX-AMI Investigators. Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. Eur Heart J 31 (2010), 1701–1707.
46. 46 Dziewierz, A., Siudak, Z., Rakowski, T., et al. Impact of multivessel coronary artery disease and noninfarct-related artery revascularization on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER registry). Am J Cardiol 106 (2010), 342–347.
47. 47 Bauer, T., Zeymer, U., Hochadel, M., et al. Prima-vista multi-vessel percutaneous coronary intervention in haemodynamically stable patients with acute coronary syndromes: analysis of over 4,400 patients in the EHS-PCI registry. Int J Cardiol 166 (2013), 596–600.
48. 48 Jaguszewski, M., Radovanovic, D., Nallamothu, B.K., et al., AMIS Plus Investigators. Multivessel versus culprit vessel percutaneous coronary intervention in ST-elevation myocardial infarction: is more worse?. EuroIntervention 9 (2013), 909–915.
49. 49 Santos, A.R., Piçarra, B.C., Celeiro, M., et al., Investigadores do Registo Nacional de Síndromes Coronárias Agudas. Multivessel approach in ST-elevation myocardial infarction: impact on in-hospital morbidity and mortality. Rev Port Cardiol 33 (2014), 67–73.
50. 50 Jeger, R., Jaguszewski, M., Nallamothu, B.N., et al., AMIS Plus Investigators. Acute multivessel revascularization improves 1-year outcome in ST-elevation myocardial infarction: a nationwide study cohort from the AMIS Plus registry. Int J Cardiol 172 (2014), 76–81.
51. 51 Manari, A., Varani, E., Guastaroba, P., et al. Long-term outcome in patients with ST segment elevation myocardial infarction and multivessel disease treated with culprit-only, immediate, or staged multivessel percutaneous revascularization strategies: insights from the REAL registry. Catheter Cardiovasc Interv 84 (2014), 912–922.
52. 52 Roe, M.T., Cura, F.A., Joski, P.S., et al. Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction. Am J Cardiol 88 (2001), 170–173.
53. 53 Hannan, E.L., Samadashvili, Z., Walford, G., et al. Culprit vessel percutaneous coronary intervention versus multivessel and staged coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. J Am Coll Cardiol Intv 3 (2010), 22–31.
54. 54 Iqbal, M.B., Ilsley, C., Kabir, T., et al., London Heart Attack Centre (HAC) Group Investigators. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment–elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London. Circ Cardiovasc Qual Outcomes 7 (2014), 936–943.
55. 55 Dambrink, J.H., Debrauwere, J.P., van 't Hof, A.W., et al. Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines?. EuroIntervention 5 (2010), 968–975.
56. 56 Ghani, A., Dambrink, J.H., van 't Hof, A.W., et al. Treatment of non-culprit lesions detected during primary PCI: long-term follow-up of a randomised clinical trial. Neth Heart J 20 (2012), 347–353.
57. 57 Hlinomaz O. Multivessel coronary disease diagnosed at the time of primary PCI for STEMI: complete revascularization versus conservative strategy: the PRAGUE 13 trial. Paper presented at: EuroPCR; May 19, 2015; Paris, France.
58. 58 Henriques JPS. EXPLORE: a prospective randomized trial of chronic total occlusion intervention versus medical therapy after successful primary angioplasty in patients with ST-segment elevation. Paper presented at: TCT Scientific Symposium; October 11-15, 2015; San Francisco, CA. Available at: http://www.tctmd.com/show.aspx?id=131921. Accessed June 22, 2016.
59. 59 Ochala, A., Smolka, G.A., Wojakowski, W., et al. The function of the left ventricle after complete multivessel one-stage percutaneous coronary intervention in patients with acute myocardial infarction. J Invasive Cardiol 16 (2004), 699–702.
60. 60 Tarasov, R.S., Ganyukov, V.I., Protopopov, A.V., et al. Six month results of randomized clinical trial: multivessel stenting versus staged revascularization for ST-elevation myocardial infarction patients with second generation drug eluting stents. Clin Med Res 3 (2014), 125–129.
61. 61 Rigattieri, S., Biondi-Zoccai, G., Silvestri, P., et al. Management of multivessel coronary disease after ST elevation myocardial infarction treated by primary angioplasty. J Interv Cardiol 21 (2008), 1–7.
62. 62 Han, Y.L., Wang, B., Wang, X.Z., et al. Comparative effects of percutaneous coronary intervention for infarct-related artery only or for both infarct- and non-infarct-related arteries in patients with ST-elevation myocardial infarction and multi-vessel disease. Chin Med J (Engl) 121 (2008), 2384–2387.
63. 63 Chen, H.C., Tsai, T.H., Fang, H.Y., et al. Benefit of revascularization in non-infarct-related artery in multivessel disease patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Int Heart J 51 (2010), 319–324.
64. 64 Ma, L.X., Lu, Z.H., Wang, L., et al. Culprit vessel only versus “one-week” staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction. J Geriatr Cardiol 12 (2015), 226–231.
65. 65 Russo, J.J., Wells, G.A., Chong, A.Y., et al., CAPITAL Investigators. Safety and efficacy of staged percutaneous coronary intervention during index admission for ST-elevation myocardial infarction with multivessel coronary disease (insights from the University of Ottawa Heart Institute STEMI registry). Am J Cardiol 116 (2015), 1157–1162.
66. 66 Barringhaus, K.G., Park, K.L., McManus, D.D., et al., GRACE Investigators. Outcomes from patients with multi-vessel disease following primary PCI: staged PCI imparts very low mortality. Catheter Cardiovasc Interv 77 (2011), 617–622.
67. 67 Lee, H.W., Hong, T.J., Yang, M.J., et al., Korea Acute Myocardial Infarction Registry Investigators. Comparison of infarct-related artery vs multivessel revascularization in ST-segment elevation myocardial infarction with multivessel disease: analysis from Korea Acute Myocardial Infarction registry. Cardiol J 19 (2012), 256–266.
68. 68 Toyota, T., Shiomi, H., Taniguchi, T., et al. Culprit vessel-only vs. staged multivessel percutaneous coronary intervention strategies in patients with multivessel coronary artery disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Circ J 80 (2016), 371–378.
69. 69 Maamoun, W., Elkhaeat, N., Elarasy, R., Safety and feasibility of complete simultaneous revascularization during primary PCI in patients with STEMI and multi-vessel disease. Egyptian Heart J 63 (2011), 39–43.
70. 70 Kornowski, R., Mehran, R., Dangas, G., et al., HORIZONS-AMI Trial Investigators. Prognostic impact of staged versus “one-time” multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol 58 (2011), 704–711.
71. 71 Jensen, L.O., Thayssen, P., Farkas, D.K., et al. Culprit only multivessel coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease. EuroIntervention 8 (2012), 456–464.
72. 72 LeLorier, J., Grégoire, G., Benhaddad, A., et al. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 337 (1997), 536–542.
73. 73 Sethi, A., Bahekar, A., Bhuriya, R., et al. Complete versus culprit only revascularization in acute ST elevation myocardial infarction: a meta-analysis. Catheter Cardiovasc Interv 77 (2011), 163–170.
74. 74 Navarese, E.P., De Servi, S., Buffon, A., et al. Clinical impact of simultaneous complete revascularization vs. culprit only primary angioplasty in patients with ST-elevation myocardial infarction and multivessel disease: a meta-analysis. J Thromb Thrombolysis 31 (2011), 217–225.
75. 75 Bangalore, S., Kumar, S., Poddar, K.L., et al. Meta-analysis of multivessel coronary artery revascularization versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease. Am J Cardiol 107 (2011), 1300–1310.
76. 76 Vlaar, P.J., Mahmoud, K.D., Holmes, D.R. Jr., et al. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis. J Am Coll Cardiol 58 (2011), 692–703.
77. 77 Takagi, H., Umemoto, T., Multi- versus single-vessel percutaneous coronary intervention for ST-elevation myocardial infarction with multi-vessel disease. Int J Cardiol 152 (2011), 97–99.
78. 78 Lu, C., Huang, H., Li, J., et al. Complete versus culprit-only revascularization during primary percutaneous coronary intervention in ST-elevation myocardial infarction patients with multivessel disease: a meta-analysis. Kaohsiung J Med Sci 29 (2013), 140–149.
79. 79 Bagai, A., Thavendiranathan, P., Sharieff, W., et al. Non-infarct-related artery revascularization during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis. Am Heart J 166 (2013), 684–693.e1.
80. 80 Bainey, K.R., Mehta, S.R., Lai, T., et al. Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis. Am Heart J 167 (2014), 1–14.e2.
81. 81 Pandit, A., Aryal, M.R., Aryal Pandit, A., et al. Preventive PCI versus culprit lesion stenting during primary PCI in acute STEMI: a systematic review and meta-analysis. Open Heart, 1, 2014, e000012.
82. 82 Zhang, D., Song, X., Lv, S., et al. Culprit vessel only versus multivessel percutaneous coronary intervention in patients presenting with ST-segment elevation myocardial infarction and multivessel disease. PLoS One, 9, 2014, e92316.
83. 83 Sekercioglu, N., Spencer, F.A., Lopes, L.C., et al. Culprit vessel only vs immediate complete revascularization in patients with acute ST-segment elevation myocardial infarction: systematic review and meta-analysis. Clin Cardiol 37 (2014), 765–772.
84. 84 Dahal, K., Rijal, J., Panta, R., et al. Multi-vessel versus culprit-vessel and staged percutaneous coronary intervention in STEMI patients with multivessel disease: a meta-analysis of randomized controlled trials. Cardiovasc Revasc Med 15 (2014), 408–413.
85. 85 Moretti, C., D'Ascenzo, F., Quadri, G., et al. Management of multivessel coronary disease in STEMI patients: a systematic review and meta-analysis. Int J Cardiol 179 (2015), 552–557.
86. 86 Briasoulis, A., Afonso, L., Palla, M., et al. Culprit-vessel versus complete revascularization during primary angioplasty in ST-elevation myocardial infarction: an updated meta-analysis. Int J Cardiol 178 (2015), 171–174.
87. 87 Sardar, P., Chatterjee, S., Giri, J., et al. Intervention strategies for multi-vessel disease in patients with ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. Int J Cardiol 179 (2015), 225–227.
88. 88 Song, Y.J., Shin, H.C., Yang, J.I., et al. Preventive versus culprit-only percutaneous coronary intervention in ST-elevation myocardial infarction patients with multivessel disease: a meta-analysis. J Interv Cardiol 28 (2015), 1–13.
89. 89 Rasoul, S., van Ommen, V., Vainer, J., et al. Multivessel revascularisation versus infarct-related artery only revascularisation during the index primary PCI in STEMI patients with multivessel disease: a meta-analysis. Neth Heart J 23 (2015), 224–231.
90. 90 Bangalore, S., Toklu, B., Wetterslev, J., Complete versus culprit-only revascularization for ST-segment–elevation myocardial infarction and multivessel disease. A meta-analysis and trial sequential analysis of randomized trials. Circ Cardiovasc Interv, 8, 2015, e002142.
91. 91 Sarathy, K., Nagaraja, V., Kapur, A., et al. Target-vessel versus multivessel revascularisation in ST-elevation myocardial infarction: a meta-analysis of randomised trials. Heart Lung Circ 24 (2015), 327–334.
92. 92 Bittl, J.A., Tamis-Holland, J.E., Lang, C.D., et al. Outcomes after multivessel or culprit-vessel intervention for ST-elevation myocardial infarction in patients with multivessel coronary disease: a Bayesian cross-design meta-analysis. Cathet Cardiovasc Interv 86:Suppl 1 (2015), S15–S22.
93. 93 El-Hayek, G.E., Gershlick, A.H., Hong, M.K., et al. Meta-analysis of randomized controlled trials comparing multivessel versus culprit-only revascularization for patients with ST-segment elevation myocardial infarction and multivessel disease undergoing primary percutaneous coronary intervention. Am J Cardiol 115 (2015), 1481–1486.
94. 94 Kowalewski, M., Schulze, V., Berti, S., et al. Complete revascularization in ST-elevation myocardial infarction and multivessel disease: meta-analysis of randomized controlled trials. Heart 101 (2015), 1309–1317.
95. 95 Elgendy, I.Y., Wen, X., Mahmoud, A., Bavry, A.A., Complete versus culprit-only revascularization for patients with multi-vessel disease undergoing primary percutaneous coronary intervention: an updated meta-analysis of randomized trials. Catheter Cardiovasc Interv, 2015 Nov 3 [E-pub ahead of print].
96. 96 Spencer, F.A., Sekercioglu, N., Prasad, M., et al. Culprit vessel versus immediate complete revascularization in patients with ST-segment myocardial infarction-a systematic review. Am Heart J 170 (2015), 1133–1139.
97. 97 Bajaj, N.S., Kalra, R., Aggarwal, H., et al. Comparison of approaches to revascularization in patients with multivessel coronary artery disease presenting with ST-segment elevation myocardial infarction: meta-analyses of randomized control trials. J Am Heart Assoc, 4, 2015, e002540.
98. 98 Marenzi, G., Assanelli, E., Campodonico, J., et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 150 (2009), 170–177.
99. 99 Hanratty, C.G., Koyama, Y., Rasmussen, H.H., et al. Exaggeration of nonculprit stenosis severity during acute myocardial infarction: implications for immediate multivessel revascularization. J Am Coll Cardiol 40 (2002), 911–916.
100. 100 De Bruyne, B., Pijls, N.H., Kalesan, B., et al., FAME 2 Trial Investigators. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367 (2012), 991–1001.
101. 101 Ntalianis, A., Sels, J.W., Davidavicius, G., et al. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. J Am Coll Cardiol Intv 3 (2010), 1274–1281.